CELLMED (셀메드)

Cellmed Orthocellular Medicine and Pharmaceutical Association (셀메드 세포교정의약학회)
권호 표지
DOI QR코드

DOI QR Code

Quality Control of Majoon-e-Nisyan and its Acute Oral Toxicity Study in Experimental Rats

  • Shaikh, Masud (Department of Ilmul-Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders (formerly CRIUM), Opp. ESI Hospital) ;
  • Husain, Gulam M. ((Pharmacology), National Research Institute of Unani Medicine for Skin Disorders (formerly CRIUM), Opp. ESI Hospital) ;
  • Naikodi, Mohammed Abdul Rasheed ((Chemistry), Drug Standardization Research Unit(DSRU), National Research Institute of Unani Medicine for Skin Disorders (formerly CRIUM), Opp. ESI Hospital) ;
  • Kazmi, Munawwar H. (Department of Ilmul-Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders (formerly CRIUM), Opp. ESI Hospital) ;
  • Viquar, Uzma (Department of Ilmul-Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders (formerly CRIUM), Opp. ESI Hospital)
  • Received : 2020.09.19
  • Accepted : 2021.01.06
  • Published : 2021.02.26
Download PDF
⟨ Previous Next ⟩

Abstract

The clinical condition Amnesia causes difficulty in learning new information and the inability to recall past events. It is primarily concerned with recent memory loss. Majoon-e-Nisyan (MJN) is a polyherbal Unani formulation, present in a semi-solid form. It is widely used potent drug of the Unani System of Medicine (USM) for treating Nisyan (amnesia). In the present study polyherbal Unani formulation, MJN has been studied for its quality control and acute toxicity. Standardization (quality control) of drugs deals with drug identity, drug quality and purity determination. Standardization of MJN had been done as per the Unani pharmacopoeial parameters approved by World Health Organization (WHO) - Pharmacognostical parameters, Physico-chemical parameters, high-performance thin-layer chromatography (HPTLC), microbial load, aflatoxin, and heavy metals. Solvents and chemicals used in the study were of analytical grade and used instrument were calibrated. By conducting an acute oral toxicity study in rats, the safety of MJN was assessed. The limit test method of OECD guideline 425 was followed in the study. Results of standardization and standard operating procedures (SOPs) for preparation of MJN may serve as the standard reference in the future. The data generated in the study for the quality control of MJN proved the quality of formulation and shows that MJN is not toxic in rats following acute dosing up to 2000 mg/kg bw. The data obtained in the paper for MJN may be used as a standard guideline for preparation of the formulation which can save time, cost, and resources for future research endeavours.

Keywords

References

  1. Afaq SH, Tajuddin, Siddiqui MMH. Standardization of herbal drugs. (Aligarh, India: Publication AMU Aligarh), pp. 100, 1994.
  2. Alam M, Khan H, Samiullah L, Siddique KM. A Review on Phytochemical and Pharmacological study of Kundur (Boswellia serrate Roxb.) - A Unani Drug. Journal of applied Pharmaceutical Science. 2012; 02(03): pp.148-156.
  3. Amit K, Vandana. Medicinal Property of Acoruscalamus. Journal of Drug Delivery and Therapeutics. 2013;3(3):143-44.
  4. Anonymous. Physico-Chemical Standards of Unani Formulations, Government of India, First Edition, Part 4th, (New Delhi, India: CCRUM, Department of AYUSH, Ministry of Health and Family Welfare), pp. 44, 140,144-145, 149, 164 -177, 2004.
  5. Anonymous. National Formulary of Unani Medicine, Government of India, First Edition, II (I), (New Delhi, India: CCRUM, Department of AYUSH, Ministry of Health and Family Welfare), pp. 77, 2009.
  6. Anonymous. Unani Pharmacopoeia of India.Government of India, First Edition, II(II), (New Delhi, India: CCRUM, Department of AYUSH, Ministry of Health and Family Welfare), pp. 113-115, 158-159, 162-164, 175-190, 205-207, 209, 269-270, 2010.
  7. Anonymous. Indian Pharmacopoeia. Government of India, First Edition, (New Delhi, India: Ministry of Health and Family Welfare), 2018.
  8. Anderson JM, Baird Parker AC. J. Appl. Bacteriol. 1975; 39:111. https://doi.org/10.1111/j.1365-2672.1975.tb00551.x
  9. Anonymous. Compendium of CPCSEA. Government of India, (New Delhi, India: Committee for the Purpose of Control and Supervision of Experiments on Animals, Animal Welfare Division, Ministry of Environment, Forest & Climate Change), 2018.
  10. Eyo AA. Fish Processing Technology in the Tropic National Institute for Freshwater Fisheries Research (NIFFR). New Bussa. 2001:10-170.
  11. Fan TP, et al. Future development of global regulations of Chinese herbal products. J. Ethno-pharmacol. 2012.
  12. Forbes BA, Sahm AS, Weissfeld DF. Bailey and Scotts Diagnostic Microbiology. 10th ed. (St. Louis, USA: Mosby Inc.), 1998.
  13. Goldman L, et al. Textbook of Medicine. 21st ed. (Singapore, Hartcourt Asia Pvt. Ltd), pp. 2038-42, 2001.
  14. Goodman, Gilman. The Pharmacological Basis of Therapeutics. 10th ed. (U.S.A: McGraw-Hill, Medical publishing Division), pp. 1687, 2001.
  15. Greenberg AE, Trussel RR, Clesceri LS. Standard Methods for the Examination of water and waste water. 16th ed. (Washington D.C., USA: APHA), 1985.
  16. Gunn BA, Ohashi DK, Gaydos CA, Holt ES. J. Clin. Microbiol. 1977;5(6):650. https://doi.org/10.1128/jcm.5.6.650-655.1977
  17. Hansen W, Yourassawsky EJ. Clin. Microbiol. 1984; 20:1177. https://doi.org/10.1128/JCM.20.6.1177-1179.1984
  18. Kremen S, Mendez MF, Wilterdink JL. Transient Global Amnesia. Available at: www.uptodate.com/contents/transient-globalamnesia#H17(accessed on August 5th 2019)
  19. Kumar RD, Ramesh V, Kumar VP, Kumar VK, Swaminaidu P. A review on amnesia. Int. J. Allied Med. Sci. and Clin. Research. 2013; 1(1):34-37.
  20. Lachman L, Liberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. (Mumbai, India: Varghese Publishing House), pp. 67,183,315 -316, 295,297, 1991.
  21. Liu Y, Wu F. Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment. Environ Health Perspect. 2010;118(6):818-824. https://doi.org/10.1289/ehp.0901388
  22. Majeed, Prakash L. The Medicinal Uses of Pepper. International Pepper News. 2000; 25(1): pp.23-31.
  23. Malhotra S, Singh AP. Medicinal property of Ginger. Dept.of Pharmacology, PGIMER, Chandigarh, Natural Product Radiance. 2003; 2(6): pp.296-301.
  24. OECD guideline 425. Acute Oral Toxicity - Up-and-Down-Procedure (UDP), 2008.
  25. Oyebamiji OF, Fagbohun TR, Olubanjo OO. Fungal Infestation and Nutrient Quality of Traditionally Smoke-Dried Freshwater Fish. Turkish Journal of Fisheries and Aquatic Science. 2008; 8:7-13.
  26. Rambach A. Environment. Microbiol. 1990; 56:301. https://doi.org/10.1128/AEM.56.1.301-303.1990
  27. Wallis TE. TextBook of Pharmacognosy. 5th ed. (New Delhi, India: CBS Publishers and Distributors), pp. 578, 2004.